| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000043746 |
| Receipt No. | R000049911 |
| Scientific Title | Evaluating the Effects of Artificial Intelligence-Aided Health Guidance on Personal Health Promotion: A Randomized Controlled Trial |
| Date of disclosure of the study information | 2021/03/26 |
| Last modified on | 2021/05/21 (Ver. 2) |
| Basic information | ||
| Public title | Evaluating the Effects of Artificial Intelligence-Aided Health Guidance on Personal Health Promotion: A Randomized Controlled Trial | |
| Acronym | Evaluating the Effects of Artificial Intelligence-Aided Health Guidance on Personal Health Promotion | |
| Scientific Title | Evaluating the Effects of Artificial Intelligence-Aided Health Guidance on Personal Health Promotion: A Randomized Controlled Trial | |
| Scientific Title:Acronym | Evaluating the Effects of Artificial Intelligence-Aided Health Guidance on Personal Health Promotion | |
| Region |
|
|
| Condition | ||
| Condition | Obesity | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study clarifies whether health guidance based on health prediction using artificial intelligence is more effective than the existing health guidance process in improving the individuals' health through a randomized controlled trial among health checkup recipients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Mean change in body mass index (BMI) values between the intervention year and the following year for each group. |
| Key secondary outcomes | Mean change in the following parameters between the intervention year and the following year for each group:
Weight, abdominal circumference, blood pressure (systolic, diastolic), liver function (AST, ALT, GTP), lipids (triglycerides, LDL/HDL cholesterol), blood glucose (fasting blood glucose, HbA1c), renal function (creatinine, eGFR), uric acid level, each questionnaire in the physical examination, and questions to be prepared for the study. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | Health guidance will be provided using an AI-based health prediction results table, which will highlight items requiring improvement. | |
| Interventions/Control_2 | Health guidance will be provided using the normal results table that is usually used in health guidance (not by AI-based results). | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Examinees who undergo health-checkups at Yamanashi Koseiren Health Care Center from April 1, 2021, to March 31, 2023, and meet the following conditions.
(1) Received a health-checkup at the same facility in the previous year. (2) Body mass index (BMI) at the time of examination in the previous year was 22 or higher. (3) The age at the time of health-checkup is 74 years or younger. (4) Patients who answered that they do not have regular hospital visits. (5) Patients who give written consent for participation in this study. (Registrations from April 1, 2022 to March 31, 2023 is limited to the situation where the required number of cases could not be collected in the fiscal year 2021.) |
|||
| Key exclusion criteria | The exclusion criteria include:
(1) Participants under 16 years of age. (2) Patients unable to receive health guidance by staff due to physical, mental, or other reasons or who are expected to be constrained in the quality of health guidance. |
|||
| Target sample size | 2720 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Faculty of Medicine, University of Yamanashi | ||||||
| Division name | Department of Health Sciences | ||||||
| Zip code | 4093898 | ||||||
| Address | 1110, Shimokato, Chuo, Yamanashi, Japan | ||||||
| TEL | 0552739566 | ||||||
| tohoka@yamanashi.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Faculty of Medicine, University of Yamanashi | ||||||
| Division name | Department of Health Sciences | ||||||
| Zip code | 4093898 | ||||||
| Address | 1110, Shimokato, Chuo, Yamanashi, Japan | ||||||
| TEL | 0552739566 | ||||||
| Homepage URL | |||||||
| tohoka@yamanashi.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Health Sciences, Faculty of Medicine, University of Yamanashi. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of education, Japan |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Yamanashi Koseiren Health Care Center |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Department of Health Sciences, Faculty of Medicine, University of Yamanashi. |
| Address | 1110, Shimokato, Chuo, Yamanashi, Japan |
| Tel | 0552739566 |
| tohoka@yamanashi.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049911 |